| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Thyroid Division (N.T., M.J.B., J.W.H., P.R.L.), Department of Medicine, Brigham and Womens Hospital and Harvard Medical School, Boston, Massachusetts 02115; Department of Internal Medicine III (E.K., T.J.V.), Erasmus University Medical School, 3000 DR Rotterdam, The Netherlands
Address all correspondence and requests for reprints to: Theo J. Visser, Ph.D., Department of Internal Medicine III, Erasmus University Medical School, PO Box 1738, Room Bd 234, 3000 DR Rotterdam, The Netherlands.
The bioactivity of thyroid hormone is determined to a large extent by
the monodeiodination of the prohormone T4 by the hepatic
selenoenzyme type I iodothyronine deiodinase (ID1), i.e.
by outer ring deiodination (ORD) to the active hormone T3,
or by inner ring deiodination (IRD) to the inactive metabolite
rT3. ID1 also catalyzes the IRD of T3 and the
ORD of rT3, both to T2, as well as the
deiodination of different iodothyronine sulfates, e.g.
IRD of T3S and ORD of T2S. Previous studies
have indicated important differences in catalytic specificity between
dog ID1 (dID1) and human ID1 (hID1), in particular with respect to the
ORD of rT3. This study was done to investigate the
relationship between structure and catalytic function of this enzyme by
comparing the deiodination of T4, T3,
rT3, T3S, and T2S by native dID1
and hID1 in liver microsomes as well as by recombinant wild-type,
chimeric and mutated d/hID1 enzymes expressed in HEK293 cells. With
both native and recombinant wild-type enzymes, the substrate
specificity was T3S > T2S
rT3 >> T4 > T3 for dID1, and
rT3 >> T2S
T3S >
T4
T3 for hID1. Whereas ORD of
T4 and of T4, T3, and
T3S showed relatively little variation between the
different d/hID1 constructs, large differences were found for the ORD
of rT3 and T2S. Both reactions were favored by
the presence of the amino acids G, E and, in particular, F, present in
hID1 at positions 45, 46, and 65, instead of the dID1 residues N, G,
and L, respectively. However, although ORD of rT3 was not
affected by the presence (hID1) or absence (dID1) of the TGMTR(4852)
sequence, the ORD of T2S was markedly inhibited by the
presence of this sequence. Therefore, we have identified structural
elements in ID1 that have substrate-specific impacts on deiodination.
Our results suggest the specific interaction of the mono-substituted
inner ring of the substrates rT3 and T2S but
not the disubstituted inner ring of T3, T3S, or
T4, with the aromatic ring of F65 in ID1, perhaps by
-
interactions.
This article has been cited by other articles:
![]() |
J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont Selenium, the Thyroid, and the Endocrine System Endocr. Rev., December 1, 2005; 26(7): 944 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. M. Klaren, R. Haasdijk, J. R. Metz, L. M. C. Nitsch, V. M. Darras, S. Van der Geyten, and G. Flik Characterization of an Iodothyronine 5'-Deiodinase in Gilthead Seabream (Sparus auratus) that Is Inhibited by Dithiothreitol Endocrinology, December 1, 2005; 146(12): 5621 - 5630. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G J M Kuiper, W. Klootwijk, and T. J Visser Expression of recombinant membrane-bound type I iodothyronine deiodinase in yeast J. Mol. Endocrinol., June 1, 2005; 34(3): 865 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. J. M. Kuiper, F. Wassen, W. Klootwijk, H. van Toor, E. Kaptein, and T. J. Visser Molecular Basis for the Substrate Selectivity of Cat Type I Iodothyronine Deiodinase Endocrinology, December 1, 2003; 144(12): 5411 - 5421. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Peeters, P. J. Wouters, E. Kaptein, H. van Toor, T. J. Visser, and G. Van den Berghe Reduced Activation and Increased Inactivation of Thyroid Hormone in Tissues of Critically Ill Patients J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3202 - 3211. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. A. Kester, E. Kaptein, C. H. Van Dijk, T. J. Roest, D. Tibboel, M. W. H. Coughtrie, and T. J. Visser Characterization of Iodothyronine Sulfatase Activities in Human and Rat Liver and Placenta Endocrinology, March 1, 2002; 143(3): 814 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases Endocr. Rev., February 1, 2002; 23(1): 38 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Richard, R. Hume, E. Kaptein, E. L. Stanley, T. J. Visser, and M. W. H. Coughtrie Sulfation of Thyroid Hormone and Dopamine during Human Development: Ontogeny of Phenol Sulfotransferases and Arylsulfatase in Liver, Lung, and Brain J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2734 - 2742. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Sanders, S. Van der Geyten, E. Kaptein, V. M. Darras, E. R. Kühn, J. L. Leonard, and T. J. Visser Cloning and Characterization of Type III Iodothyronine Deiodinase from the Fish Oreochromis niloticus Endocrinology, August 1, 1999; 140(8): 3666 - 3673. [Abstract] [Full Text] |
||||
![]() |
M. H. A. Kester, E. Kaptein, T. J. Roest, C. H. van Dijk, D. Tibboel, W. Meinl, H. Glatt, M. W. H. Coughtrie, and T. J. Visser Characterization of Human Iodothyronine Sulfotransferases J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1357 - 1364. [Abstract] [Full Text] |
||||
![]() |
K. Richard, R. Hume, E. Kaptein, J. P. Sanders, H. van Toor, W. W. de Herder, J. C. den Hollander, E. P. Krenning, and T. J. Visser Ontogeny of Iodothyronine Deiodinases in Human Liver J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2868 - 2874. [Abstract] [Full Text] |
||||
![]() |
E. Kaptein, G. A. C. van Haasteren, E. Linkels, W. J. de Greef, and T. J. Visser Characterization of Iodothyronine Sulfotransferase Activity in Rat Liver Endocrinology, December 1, 1997; 138(12): 5136 - 5143. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Van der Geyten, J. P. Sanders, E. Kaptein, V. M. Darras, E. R. Kuhn, J. L. Leonard, and T. J. Visser Expression of Chicken Hepatic Type I and Type III Iodothyronine Deiodinases during Embryonic Development Endocrinology, December 1, 1997; 138(12): 5144 - 5152. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Sanders, S. Van der Geyten, E. Kaptein, V. M. Darras, E. R. Kuhn, J. L. Leonard, and T. J. Visser Characterization of a Propylthiouracil-Insensitive Type I Iodothyronine Deiodinase Endocrinology, December 1, 1997; 138(12): 5153 - 5160. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Sun, J. W. Harney, M. J. Berry, and P. R. Larsen The Role of the Active Site Cysteine in Catalysis by Type 1 Iodothyronine Deiodinase Endocrinology, December 1, 1997; 138(12): 5452 - 5458. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Leonard, T. J. Visser, and D. M. Leonard Characterization of the Subunit Structure of the Catalytically Active Type I Iodothyronine Deiodinase J. Biol. Chem., January 19, 2001; 276(4): 2600 - 2607. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |